Skip to content
2000
image of Antidepressant Potential of Hispidulin Present in S. barbata D. Don: Mechanistic Insights through Neurochemical and Behavioral Assessments

Abstract

Background and Aim

This study aims to investigate the antidepressant properties of Hispidulin, a flavonoid present in D. Don. The selection of Hispidulin stems from its notable inhibitory activity against Xanthine Oxidase (XO), a parameter in the pathophysiology of depression.

Material and Methods

Mice were subjected to a rigorous evaluation using a murine model of Chronic Unpredictable Mild Stress (CUMS) to induce depression for 21 days and antidepressant properties were rigorously assessed using the Tail Suspension Test (TST), Forced Swim Test (FST), and Open Field Test (OFT). Imipramine and fluoxetine were used as standard drugs. Additionally, neurochemical analyses were conducted to quantify serotonin (5-HT), norepinephrine (NE), and dopamine (DA) levels in the cortex, hippocampus, and hypothalamus. Further mechanistic insights were sought through the estimation of monoamine oxidase (MAO) activity and assessment of antioxidant enzyme levels in the brain. Plasma nitrite and corticosterone levels were also measured to delineate the underlying mechanism of action.

Results

Hispidulin demonstrated significant antidepressant effects, as evidenced by reduced immobility time in TST and FST and increased exploratory behavior in OFT. Neurochemical analysis revealed restoration of 5-HT, NE, and DA levels in key brain regions. Furthermore, Hispidulin modulated MAO activity and enhanced antioxidant enzyme levels in the brain. Plasma nitrite levels were elevated, indicating enhanced nitric oxide synthesis, while corticosterone levels were reduced.

Conclusion

Our findings indicate that Hispidulin exerts potent antidepressant effects, potentially mediated through its influence on monoaminergic neurotransmitters, MAO activity, and antioxidant defenses. These results provide valuable mechanistic insights into the antidepressant action of Hispidulin, supporting its potential therapeutic application in depressive disorders.

Loading

Article metrics loading...

/content/journals/cnsamc/10.2174/0118715249331487241021053730
2024-11-04
2025-01-29
Loading full text...

Full text loading...

References

  1. Institute of health metrics and evaluation. 2019 Available from: https://vizhub.healthdata.org/gbd-results/
  2. Woody C.A. Ferrari A.J. Siskind D.J. Whiteford H.A. Harris M.G. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J. Affect. Disord. 2017 219 86 92 10.1016/j.jad.2017.05.003 28531848
    [Google Scholar]
  3. Cui L. Li S. Wang S. Wu X. Liu Y. Yu W. Wang Y. Tang Y. Xia M. Li B. Major depressive disorder: Hypothesis, mechanism, prevention and treatment. Signal Transduct. Target. Ther. 2024 9 1 30 10.1038/s41392‑024‑01738‑y 38331979
    [Google Scholar]
  4. Pannu A. Goyal R.K. From evidence to practice: A comprehensive analysis of side effects in synthetic anti-depressant therapy. Curr. Drug Saf. 2024 19 Advance online publication 10.2174/0115748863301630240417071353 38676478
    [Google Scholar]
  5. Braund T.A. Tillman G. Palmer D.M. Gordon E. Rush A.J. Harris A.W.F. Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: An iSPOT-D report. Transl. Psychiatry 2021 11 1 417 10.1038/s41398‑021‑01533‑1 34349116
    [Google Scholar]
  6. Saha K. Torous J. Kiciman E. De Choudhury M. Understanding side effects of antidepressants: Large-scale longitudinal study on social media data. JMIR Ment. Health 2021 8 3 e26589 10.2196/26589 33739296
    [Google Scholar]
  7. Chen Q. Rahman K. Wang S.J. Zhou S. Zhang H. Scutellaria barbata: A review on chemical constituents, pharmacological activities and clinical applications. Curr. Pharm. Des. 2020 26 1 160 175 10.2174/1381612825666191216124310 31840605
    [Google Scholar]
  8. Yuan M. Liu Y. Xiao A. Leng J. Liao L. Ma L. Liu L. The interaction of dietary flavonoids with xanthine oxidase in vitro: Molecular property-binding affinity relationship aspects. RSC Advances 2019 9 19 10781 10788 10.1039/C8RA09926J 35515322
    [Google Scholar]
  9. Battelli M.G. Polito L. Bortolotti M. Bolognesi A. Xanthine oxidoreductase‐derived reactive species: Physiological and pathological effects. Oxid. Med. Cell. Longev. 2016 2016 1 3527579 10.1155/2016/3527579 26823950
    [Google Scholar]
  10. Jahromy M.H. Baghchesara B. Javanshir S. Effects of Allopurinol as a xanthine oxidase inhibitor on depressive-like behavior of rats and changes in serum BDNF level. IBRO Neurosci. Rep. 2022 13 373 377 10.1016/j.ibneur.2022.10.004 36340441
    [Google Scholar]
  11. Patel K. Patel D.K. Medicinal importance, pharmacological activities, and analytical aspects of hispidulin: A concise report. J. Tradit. Complement. Med. 2017 7 3 360 366 10.1016/j.jtcme.2016.11.003 28725632
    [Google Scholar]
  12. Dhingra D. Bhankher A. Behavioral and biochemical evidences for antidepressant-like activity of palmatine in mice subjected to chronic unpredictable mild stress. Pharmacol. Rep. 2014 66 1 1 9 10.1016/j.pharep.2013.06.001 24905299
    [Google Scholar]
  13. Dhingra D. Deepak D. Antidepressant-like activity of flowers of Tecomella undulata in mice subjected to chronic unpredictable mild stress. Asian J. Pharm. Clin. Res. 2019 12 1 130 138 10.22159/ajpcr.2019.v12i1.28981
    [Google Scholar]
  14. Dhingra D. Valecha R. Evaluation of the antidepressant-like activity of Convolvulus pluricaulis choisy in the mouse forced swim and tail suspension tests. Med. Sci. Monit. 2007 13 7 BR155 BR161 17599020
    [Google Scholar]
  15. Charles M. McEwan J. MAO activity in rabbit serum. Methods in Enzymology Tabor H. Tabor C.W. New York Academic Press 1977 692 698
    [Google Scholar]
  16. Schurr A. Livne A. Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochem. Pharmacol. 1976 25 10 1201 1203 10.1016/0006‑2952(76)90369‑5 938542
    [Google Scholar]
  17. Stahl W. Sies H. β-Carotene and other carotenoids in protection from sunlight. Am. J. Clin. Nutr. 2012 96 5 1179S 1184S 10.3945/ajcn.112.034819 23053552
    [Google Scholar]
  18. Misra H.P. Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972 247 10 3170 3175 10.1016/S0021‑9258(19)45228‑9 4623845
    [Google Scholar]
  19. Aebi H. Catalase in vitro. Methods Enzymol. 1984 105 121 126 10.1016/S0076‑6879(84)05016‑3 6727660
    [Google Scholar]
  20. Ohkawa H. Ohishi N. Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979 95 2 351 358 10.1016/0003‑2697(79)90738‑3 36810
    [Google Scholar]
  21. Green L.C. Wagner D.A. Glogowski J. Skipper P.L. Wishnok J.S. Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982 126 1 131 138 10.1016/0003‑2697(82)90118‑X 7181105
    [Google Scholar]
  22. Bartos J. Pesez M. Pure Appl. Chem. 1979 51 10 2157 2169 10.1351/pac197951102157
    [Google Scholar]
  23. Surguchov A. Bernal L. Surguchev A.A. Phytochemicals as regulators of genes involved in synucleinopathies. Biomolecules 2021 11 5 624 10.3390/biom11050624 33922207
    [Google Scholar]
  24. Antoniuk S. Bijata M. Ponimaskin E. Wlodarczyk J. Chronic unpredictable mild stress for modeling depression in rodents: Meta-analysis of model reliability. Neurosci. Biobehav. Rev. 2019 99 101 116 10.1016/j.neubiorev.2018.12.002 30529362
    [Google Scholar]
  25. Tian X. Russo S.J. Li L. Behavioral animal models and neural-circuit framework of depressive disorder. Neurosci. Bull. 2024 Advance online publication 10.1007/s12264‑024‑01270‑7 39120643
    [Google Scholar]
  26. Planchez B. Surget A. Belzung C. Animal models of major depression: Drawbacks and challenges. J. Neural Transm. (Vienna) 2019 126 11 1383 1408 10.1007/s00702‑019‑02084‑y 31584111
    [Google Scholar]
  27. Krishnan V. Nestler E.J. Animal models of depression: Molecular perspectives. Curr. Top. Behav. Neurosci. 2011 7 121 147 10.1007/7854_2010_108 21225412
    [Google Scholar]
  28. Thase M.E. The role of monoamine oxidase inhibitors in depression treatment guidelines. J. Clin. Psychiatry 2012 73 Suppl. 1 10 16 10.4088/JCP.11096su1c.02 22951237
    [Google Scholar]
  29. Somani A. Singh A.K. Gupta B. Nagarkoti S. Dalal P.K Dikshit M. Oxidative and nitrosative stress in major depressive disorder: A case control study. Brain Sci. 2022 12 2 144 10.3390/brainsci12020144 35203908
    [Google Scholar]
  30. Bajpai A. Verma A.K. Srivastava M. Srivastava R. Oxidative stress and major depression. J. Clin. Diagn. Res. 2014 8 12 CC04 CC07 10.7860/JCDR/2014/10258.5292 25653939
    [Google Scholar]
  31. Bhatt S. Nagappa A.N. Patil C.R. Role of oxidative stress in depression. Drug Discov. Today 2020 25 7 1270 1276 10.1016/j.drudis.2020.05.001 32404275
    [Google Scholar]
  32. Varghese F.P. Brown E.S. The hypothalamic-pituitary-adrenal axis in major depressive disorder: A brief primer for primary care physicians. Prim. Care Companion J. Clin. Psychiatry 2001 3 4 151 155 15014598
    [Google Scholar]
/content/journals/cnsamc/10.2174/0118715249331487241021053730
Loading
/content/journals/cnsamc/10.2174/0118715249331487241021053730
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test